Related Experiment Videos
Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial
A Al Aqeel1, O A Mojiminiyi, R Al Dashti
1Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait.
Insights
In myocardial infarction patients, low high-density lipoprotein (HDL) cholesterol was the primary lipid risk factor. Early lipid testing within 24 hours and HDL-focused interventions are recommended for secondary prevention.
Area of Science:
- Cardiology
- Clinical Lipidology
- Public Health
Background:
- Current guidelines recommend blood lipid testing within 24 hours of chest pain onset in myocardial infarction (MI) patients.
- Understanding lipid profiles in MI patients is crucial for effective secondary prevention strategies.
Purpose of the Study:
- To evaluate the adherence to and effectiveness of American College of Cardiology/American Heart Association guidelines for lipid testing in MI patients.
- To identify key lipid abnormalities and risk factors in patients presenting with acute myocardial infarction (AMI).
Main Methods:
- A cross-sectional observational study involving 83 MI patients in Kuwait.
- Lipid profiles (Total Cholesterol, HDL, Triglycerides, LDL) were measured within 24 hours of chest pain onset.
- Patients' adherence to National Cholesterol Education Program (NCEP) LDL targets and presence of metabolic syndrome were assessed.
Main Results:
- A significant proportion of patients (70%) had low HDL cholesterol and a poor HDL:TC ratio, indicating impaired lipid metabolism.
- Only 27% of patients met the NCEP guideline target for LDL cholesterol (<2.6 mmol/l).
- Metabolic syndrome was prevalent, identified in 56 patients (67.5%).
Conclusions:
- Low HDL cholesterol is identified as the predominant lipid risk factor in this cohort of MI patients in Kuwait.
- Primary prevention should prioritize interventions aimed at increasing HDL levels.
- Routine lipid profiling within 24 hours of admission and initiation of lipid-lowering therapy are recommended for secondary prevention.
Objective:
To evaluate the American College of Cardiology/American Heart Association guidelines on blood lipid testing within 24 h of the onset of chest pain in patients with myocardial infarction.
Subjects And Methods:
This is a cross-sectional observational study on 83 patients (77 male, 6 female) admitted into the Coronary Care Units of the Al-Amiri and Mubarak Al-Kabeer Hospitals, Kuwait with myocardial infarction. The lipid profiles were obtained within 24 h of the onset of chest pain. Twenty patients were on treatment with statins prior to admission. Diagnosis of myocardial infarction in all patients was based on standard criteria. Total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, and triglycerides (Tg) were measured and low-density lipoprotein (LDL) cholesterol was calculated.
Results:
Twenty-three patients had normal cardiac markers on admission but later developed increased serum markers and ECG changes of acute myocardial infarction. Mean (95% confidence interval) TC, HDL, Tg and LDL were 5.1 (4.8-5.4); 0.93 (0.88-0.98); 1.85 (1.56-2.14), and 3.39 (3.13-3.65) mmol/l, respectively. 70% of the patients had normal or only mild elevations of LDL with low HDL and poor HDL:TC ratio (<20%). Thirty-eight patients had low HDL (<0.9 mmol/l) and only 22 (27%) patients met the National Cholesterol Education Program guideline of target LDL <2.6 mmol/l. Fifty-six patients were classified as having the metabolic syndrome according to the criteria of the WHO.
Conclusion:
The findings indicate that HDL appears to be the main lipid risk factor in patients presenting with AMI in Kuwait, therefore primary prevention strategies should focus on treatment modalities that increase HDL. We recommend that the lipid profile should be done within 24 h of admission and lipid-lowering therapy initiated as part of secondary prevention strategy.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Angina IV: Management
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Coronary Artery Disease IV: Preventive Measures